These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 21410630)
21. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features. Boccon-Gibod LM; Dumonceau O; Toublanc M; Ravery V; Boccon-Gibod LA Eur Urol; 2005 Dec; 48(6):895-9. PubMed ID: 16125298 [TBL] [Abstract][Full Text] [Related]
22. The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy. Antunes AA; Srougi M; Dall'Oglio MF; Crippa A; Campagnari JC; Leite KR BJU Int; 2005 Dec; 96(9):1258-63. PubMed ID: 16287441 [TBL] [Abstract][Full Text] [Related]
23. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653 [TBL] [Abstract][Full Text] [Related]
24. The value of EZH2, p27(kip1), BMI-1 and MIB-1 on biopsy specimens with low-risk prostate cancer in selecting men with significant prostate cancer at prostatectomy. Wolters T; Vissers KJ; Bangma CH; Schröder FH; van Leenders GJ BJU Int; 2010 Jul; 106(2):280-6. PubMed ID: 19888978 [TBL] [Abstract][Full Text] [Related]
25. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. Falzarano SM; Zhou M; Hernandez AV; Moussa AS; Jones JS; Magi-Galluzzi C Urology; 2010 Sep; 76(3):682-7. PubMed ID: 20206973 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy. Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714 [TBL] [Abstract][Full Text] [Related]
28. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer. Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303 [TBL] [Abstract][Full Text] [Related]
29. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy. Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452 [TBL] [Abstract][Full Text] [Related]
30. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. King CR; McNeal JE; Gill H; Presti JC Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152 [TBL] [Abstract][Full Text] [Related]
31. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens. Poulos CK; Daggy JK; Cheng L Cancer; 2004 Aug; 101(3):527-32. PubMed ID: 15274065 [TBL] [Abstract][Full Text] [Related]
32. Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: implications for focal therapy. Sinnott M; Falzarano SM; Hernandez AV; Jones JS; Klein EA; Zhou M; Magi-Galluzzi C Prostate; 2012 Aug; 72(11):1179-86. PubMed ID: 22161896 [TBL] [Abstract][Full Text] [Related]
33. Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3). Aus G; Becker C; Lilja H; Khatami A; Pihl CG; Hugosson J Scand J Urol Nephrol; 2003; 37(6):466-70. PubMed ID: 14675918 [TBL] [Abstract][Full Text] [Related]
34. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy. Villamón-Fort R; Martínez-Jabaloyas JM; Soriano-Sarriá P; Ramos-Soler D; Pastor-Hernández F; Gil-Salom M Urol Int; 2007; 78(4):328-33. PubMed ID: 17495491 [TBL] [Abstract][Full Text] [Related]
35. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706 [TBL] [Abstract][Full Text] [Related]
36. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores? Makarov DV; Sanderson H; Partin AW; Epstein JI J Urol; 2002 Jun; 167(6):2440-2. PubMed ID: 11992053 [TBL] [Abstract][Full Text] [Related]
37. Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy. Patel DA; Presti JC; McNeal JE; Gill H; Brooks JD; King CR J Clin Oncol; 2005 Sep; 23(25):6157-62. PubMed ID: 16135482 [TBL] [Abstract][Full Text] [Related]
38. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249 [TBL] [Abstract][Full Text] [Related]